How many doses of the hepatitis B vaccine booster are required?

May 23, 2022 Source: Cainiu Health

Dr. Gao Jun

Introduction

A booster dose of the hepatitis B vaccine requires only a single injection, but the hepatitis B panel (five-item serological test) must be performed in advance. The standard hepatitis B vaccination schedule consists of three doses administered at 0, 1, and 6 months. One month after completing the full vaccination series, quantitative hepatitis B panel testing should be repeated. If the HBsAg titer is less than 1 IU/mL, HBsAg is considered negative. In such cases, revaccination with the hepatitis B vaccine is required.

In daily life, hepatitis B vaccination is commonly administered to prevent hepatitis B virus (HBV) infection. However, some individuals are uncertain about how many doses constitute a hepatitis B vaccine booster shot. So, how many doses are required for a hepatitis B vaccine booster?

How Many Doses Are Required for a Hepatitis B Vaccine Booster?

Only one dose is needed for the hepatitis B vaccine booster. However, prior assessment of the “five hepatitis B serological markers” (commonly referred to as the “hepatitis B panel”) is essential. The standard hepatitis B vaccination schedule consists of three doses administered at 0, 1, and 6 months. One month after completing the primary series, quantitative testing of the hepatitis B panel should be repeated. If the HBsAg titer is less than 1 IU/mL, HBsAg is considered negative. In such cases, re-vaccination is required—either with a full three-dose series or a single high-dose injection of 60 µg hepatitis B vaccine.

One month later, quantitative measurement of hepatitis B surface antibody (anti-HBs) must be repeated. If the anti-HBs titer exceeds 10 IU/mL following the three-dose vaccination series, no booster dose is necessary, as adequate protective antibodies have been generated. While this level of immunity provides good protection, it is not lifelong. Therefore, even after successful antibody production, it is recommended to undergo hepatitis B panel testing every 3–5 years to monitor changes in antibody titers.

If a patient develops symptoms suggestive of hepatitis B infection, regular medical evaluation at a hospital is essential. We hope this article has been helpful. Wishing you good health and happiness!

View All

Can short-acting interferon be used again after having been administered for 4 years and then discontinued for 4 years?

If the underlying disease (e.g., chronic hepatitis B or C) is currently in an active phase, with abnormal liver function or elevated viral load, and no severe baseline conditions (e.g., cirrhosis) have occurred during the 4-year period off treatment, the patient may be eligible for re-treatment—provided a physician evaluates them as having good overall tolerance and no contraindications to interferon use (such as severe cardiac or renal disease, or psychiatric history). An individualized dosing regimen would then be required.